The Allied Professionals Forum is almost here - an educational and training event where hundreds of allied health professionals come together from around the world. Its two days of extensive presentations, networking, and workshops that always leaves us feeling exhausted but at the same time re-energized and rejuvenated from hearing about all the amazing work being done around the world.
We asked the FDA to treat the approval review process of AMX0035 with urgency. Specifically, we sent a letter to FDA asking the agency to conduct a Priority Review of Amylyx’s New Drug Application (NDA) for AMX0035 and then approve it. The Priority Review is an expedited review process, as opposed to the Standard Review process, which can take upwards of a year after the agency accepts submission of the NDA.
We talked with Dr. Caroline McHutchison, postdoctoral fellow from the University of Edinburgh, to learn more about her research focused on examining the presence, onset, and evolution of cognitive and behavioral symptoms, relative to motor symptom onset and diagnosis of ALS.
The National Institutes of Health has funded a $3.6 million project to allow a team of experts to explore the intersection of environmental exposures, genetics, inflammation, and other factors to better determine what makes someone more likely to develop Amyotrophic Lateral Sclerosis, also known as Lou Gehrig’s Disease.
Jerseys, baseball bats and other items that belonged to Pete Frates, the former college baseball player whose inspiring fight with Lou Gehrig’s disease helped popularize the ALS ice bucket challenge, are being auctioned.